About 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol
1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol (PubChem CID 139416274) has the molecular formula C32H34Cl2N6O2
and a molecular weight of 605.57 g/mol. Its IUPAC name is 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol.
Molecular Properties
| Compound Name | 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol |
| PubChem CID | 139416274 |
| Molecular Formula | C32H34Cl2N6O2 |
| Molecular Weight | 605.57 g/mol |
| Exact Mass | 604.21 |
| IUPAC Name | 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol |
| SMILES | CCc1nc(-c2cccc(-c3cccc(-c4cnc(CN5CC(O)C5)c(CC)n4)c3Cl)c2Cl)cnc1CN1CC(O)C1 |
| InChI | InChI=1S/C32H34Cl2N6O2/c1-3-25-29(17-39-13-19(41)14-39)35-11-27(37-25)23-9-5-7-21(31(23)33)22-8-6-10-24(32(22)34)28-12-36-30(26(4-2)38-28)18-40-15-20(42)16-40/h5-12,19-20,41-42H,3-4,13-18H2,1-2H3 |
| InChIKey | CEKBBAOQXHSURH-UHFFFAOYSA-N |
| XLogP | 5.05 |
| TPSA | 98.50 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 605.57 |
| LogP ≤ 5 | 5.05 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol?
The IUPAC name of 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol (CID 139416274) is 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol.
What is the SMILES notation for 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol?
The canonical SMILES for 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol is CCc1nc(-c2cccc(-c3cccc(-c4cnc(CN5CC(O)C5)c(CC)n4)c3Cl)c2Cl)cnc1CN1CC(O)C1.
What is the InChIKey of 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol?
The InChIKey is CEKBBAOQXHSURH-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H34Cl2N6O2/c1-3-25-29(17-39-13-19(41)14-39)35-11-27(37-25)23-9-5-7-21(31(23)33)22-8-6-10-24(32(22)34)28-12-36-30(26(4-2)38-28)18-40-15-20(42)16-40/h5-12,19-20,41-42H,3-4,13-18H2,1-2H3.
What are the key properties of 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol?
1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol has a molecular weight of 605.57 g/mol, XLogP of 5.05, 9 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[5-[2-chloro-3-[2-chloro-3-[6-ethyl-5-[(3-hydroxyazetidin-1-yl)methyl]pyrazin-2-yl]phenyl]phenyl]-3-ethylpyrazin-2-yl]methyl]azetidin-3-ol is sourced from PubChem (CID 139416274), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).